🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the Pharmacokinetics (PK) of the Phase II tablet f...
Status
Completed
Location
Nuvisan GmbH
Start Date
2019-04-15
Trial ID
NCT03934502
Treatments Being Tested
M2951 is an investigational drug under evaluation for treatment of autoimmu...
Status
Terminated
Location
Pinnacle Research Group LLC
Start Date
2017-01-04
Trial ID
NCT02975336
The study was to evaluate the efficacy and safety of evobrutinib administer...
Status
Terminated
Location
Please Contact U.S. Medical Information
Start Date
2019-08-26
Trial ID
NCT04032158
Treatments Being Tested
M2951 is an investigational drug under evaluation for treatment of autoimmu...
Status
Completed
Location
U.S. Medical Information
Start Date
2016-07-31
Trial ID
NCT02784106
This study was to investigate the pharmacokinetic (PK) and safety of M2951 ...
Status
Completed
Location
CRS Clinical Research Services Kiel GmbH
Start Date
2020-09-30
Trial ID
NCT04546789
Treatments Being Tested
The aim of this protocol is to find out about the safety and effectiveness ...
Status
Terminated
Location
Research Site
Start Date
2017-03-07
Trial ID
NCT02975349
Treatments Being Tested
The study is to evaluate the efficacy and safety of evobrutinib administere...
Status
Terminated
Location
Research Site 752
Start Date
2020-07-02
Trial ID
NCT04338061
Treatments Being Tested
This study consisted of 2 parts: Part 1 and 2. The purpose of this study wa...
Status
Completed
Location
Nuvisan GmbH
Start Date
2021-10-04
Trial ID
NCT05064488
Treatments Being Tested
The study is to evaluate the efficacy and safety of evobrutinib administere...
Status
Terminated
Location
Research Site 629
Start Date
2020-06-12
Trial ID
NCT04338022
Treatments Being Tested
The purpose of the study is to determine the absorption, metabolism, and ex...
Status
Completed
Location
PRA Health Sciences
Start Date
2018-10-30
Trial ID
NCT03725072
Treatments Being Tested